Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIKINASDAQ:DKDCANASDAQ:LUNANASDAQ:SLGC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIKIAIkido Pharma$5.55-4.3%$5.10$3.31▼$11.48$30.44M0.9379,326 shs243,632 shsDKDCAData Knights Acquisition$0.57-16.2%$0.41$5.00▼$13.51$2.96M0.1839,705 shs5.59 million shsLUNALuna Innovations$0.84+12.0%$0.54$0.22▼$3.68$28.53M1.88215,978 shs42,216 shsSLGCStandard BioTools$2.10-4.5%$2.31$1.73▼$3.79$394.95M1.6410.83 million shs33.91 million shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIKIAIkido Pharma-4.31%-11.20%+20.65%+6.12%+193.65%DKDCAData Knights Acquisition-16.17%+47.82%+39.83%-0.71%-37.17%LUNALuna Innovations+12.00%+27.27%+68.00%+20.00%-76.20%SLGCStandard BioTools0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIKIAIkido PharmaN/AN/AN/AN/AN/AN/AN/AN/ADKDCAData Knights AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ALUNALuna Innovations0.6448 of 5 stars0.03.00.00.02.31.70.0SLGCStandard BioToolsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIKIAIkido Pharma 0.00N/AN/AN/ADKDCAData Knights Acquisition 0.00N/AN/AN/ALUNALuna Innovations 0.00N/AN/AN/ASLGCStandard BioTools 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIKIAIkido Pharma$10K3,044.18N/AN/A$19.27 per share0.29DKDCAData Knights AcquisitionN/AN/A$0.01 per share111.42($1.82) per shareN/ALUNALuna Innovations$116.61M0.24$0.28 per share3.03N/A∞SLGCStandard BioTools$97.67M4.04N/AN/A$3.00 per share0.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIKIAIkido Pharma-$7.17M-$3.88N/AN/AN/AN/A-18.21%-16.94%N/ADKDCAData Knights Acquisition$340K-$0.19N/A∞N/AN/AN/A-5.55%N/ALUNALuna Innovations$9.28MN/A0.00∞N/AN/AN/AN/AN/ASLGCStandard BioTools-$109.16M-$0.69N/AN/AN/A-159.54%-24.72%-21.62%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIKIAIkido PharmaN/AN/AN/AN/AN/ADKDCAData Knights AcquisitionN/AN/AN/AN/AN/ALUNALuna InnovationsN/AN/AN/AN/AN/ASLGCStandard BioToolsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIKIAIkido PharmaN/A29.5429.54DKDCAData Knights AcquisitionN/AN/AN/ALUNALuna InnovationsN/AN/AN/ASLGCStandard BioToolsN/A17.7917.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIKIAIkido Pharma10.88%DKDCAData Knights Acquisition35.35%LUNALuna Innovations87.46%SLGCStandard BioTools66.35%Insider OwnershipCompanyInsider OwnershipAIKIAIkido Pharma8.60%DKDCAData Knights Acquisition45.72%LUNALuna Innovations7.60%SLGCStandard BioTools14.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIKIAIkido Pharma45.49 million5.01 millionNot OptionableDKDCAData Knights Acquisition25.17 million2.81 millionNot OptionableLUNALuna Innovations39033.96 million31.38 millionOptionableSLGCStandard BioTools451188.07 million160.05 millionOptionableSLGC, AIKI, LUNA, and DKDCA HeadlinesRecent News About These CompaniesIllumina to buy SomaLogic for up to $425MJune 23, 2025 | medtechdive.comMIllumina to buy SomaLogic in deal worth up to $425MJune 23, 2025 | biopharmadive.comBIllumina to Acquire SomaLogic from Standard BioToolsJune 23, 2025 | genengnews.comGIllumina to Buy SomaLogic for Up to $425 Mln -- UpdateJune 23, 2025 | marketwatch.comIllumina picks up proteomics developer SomaLogic from Standard BioTools for $425MJune 23, 2025 | fiercebiotech.comFStandard BioTools jumps on sale of SomaLogic to IlluminaJune 23, 2025 | msn.comWhy Standard BioTools Inc.’s (LAB) Stock Is Down 5.28%April 26, 2025 | aaii.comAStandard BioTools cut to Neutral at KeyBanc on guidanceFebruary 27, 2025 | msn.comStandard BioTools announces publication on study using SomaScan PlatformJanuary 8, 2025 | markets.businessinsider.comStandard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature MedicineJanuary 8, 2025 | markets.businessinsider.comThe Standard 100: The top one hundred people shaping London in 2024October 31, 2024 | standard.co.ukSStandard BioTools Inc. Reports Q3 2024 Financial PerformanceOctober 31, 2024 | markets.businessinsider.comLAB Unveiled: The Shocking Truth Behind Standard Biotools Inc’s Latest Stock MovementsOctober 22, 2024 | bovnews.comBStandard Biotools Inc (LAB) Stock: Analyzing Its Quiet PowerOctober 2, 2024 | bovnews.comBWhy Is Standard Biotools Inc (LAB) Stock Lagging Behind -2.21% from Its 50-Day SMA?September 28, 2024 | bovnews.comBStandard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K PlatformSeptember 24, 2024 | markets.businessinsider.comStandard Biotools Inc (LAB) Stock: More Resilient Than It AppearsSeptember 10, 2024 | bovnews.comBStandard BioTools And 2 Other Penny Stocks Executives Are BuyingAugust 29, 2024 | msn.comStandard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceAugust 26, 2024 | markets.businessinsider.comStandard BioTools Shares Fall to 52-Week Low After Company Cuts GuidanceAugust 1, 2024 | marketwatch.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSLGC, AIKI, LUNA, and DKDCA Company DescriptionsAIkido Pharma NASDAQ:AIKI$5.55 -0.25 (-4.31%) As of 06/25/2025AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.Data Knights Acquisition NASDAQ:DKDCA$0.57 -0.11 (-16.17%) As of 06/25/2025Data Knights Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. Data Knights Acquisition Corp. was incorporated in 2021 and is based in Frome, the United Kingdom.Luna Innovations NASDAQ:LUNA$0.84 +0.09 (+12.00%) As of 06/26/2025 03:59 PM EasternLuna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.Standard BioTools NASDAQ:SLGCSomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Amazon: Why Some Are Growing Bearish, and Why They’re Wrong ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside Astera Labs: AI Infrastructure Play With Significant Growth Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
